How is medical technology different from pharmaceuticals?

Medical technology focuses on devices, implants and surgical products, while pharmaceuticals centre on medicines and drug development.

What drives demand for medical devices?

Surgical volumes, healthcare capacity, product innovation and global patient demand are key drivers for the medical-device segment.

Where do these firms sit on the market?

They are classified within the healthcare sector, with several featuring in the FTSE100.

How does medical technology differ from pharmaceuticals?

AZN GSK SN

2 min read | June 21, 2026 05:34 PM AEST | By Vivek Singh

Google News:

How does medical technology differ from pharmaceuticals? — Image source: Shutterstock

Recent News

3 Best ASX Dividend Stocks Supported by Strong Margins

Electro Optic Systems (ASX:EOS): Are Defence Wins Fueling a Bigger Gro...

Why More Australians Are Rethinking Term Deposits As Rates Pause

ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed At...

Make Kalkine Media
My Trusted Source

Highlights

Smith & Nephew [LSE:SN] operates across orthopaedics, wound care and sports medicine.

Medical technology broadens the UK healthcare sector beyond traditional pharmaceuticals.

AstraZeneca [LSE:AZN] and GSK [LSE:GSK] remain the larger UK-listed healthcare names.

Smith & Nephew [LSE:SN] moved back into healthcare discussions this week as broader market sentiment steadied following a volatile stretch shaped by easing Middle East tensions and shifting rate expectations. Unlike the large pharmaceutical groups, Smith & Nephew operates primarily in medical technology, spanning orthopaedics, advanced wound management and sports medicine. This positions the company within a distinct corner of the healthcare sector, one that depends on surgical volumes, product innovation and global demand for medical devices rather than the drug-development cycle that defines pharmaceutical peers.

Medical technology centres on devices, implants and surgical products rather than medicines, giving the segment a different demand profile from pharmaceutical research. Smith & Nephew [LSE:SN] generates activity through procedures such as joint replacements and wound treatments, which are influenced by healthcare system capacity and patient demand. This contrasts with the patent-driven dynamics that shape companies such as AstraZeneca [LSE:AZN] and GSK [LSE:GSK]. Together, these differing models illustrate why the healthcare sector is far broader than the headline pharmaceutical names alone.

Why does the breadth of healthcare matter to markets?

The diversity within healthcare means the sector responds to a wide range of drivers, from drug approvals to surgical demand and diagnostics. As the [FTSE100] trades near record territory amid choppy sessions, this breadth is part of what makes healthcare a recurring reference point. Pharmaceutical leaders such as AstraZeneca [LSE:AZN] and GSK [LSE:GSK] sit alongside device specialists like Smith & Nephew [LSE:SN], and together they reflect a sector whose underlying demand tends to be more structural than cyclical, even as individual companies face their own competitive and regulatory pressures.

Frequently Asked Questions

How is medical technology different from pharmaceuticals?
Medical technology focuses on devices, implants and surgical products, while pharmaceuticals centre on medicines and drug development.
What drives demand for medical devices?
Surgical volumes, healthcare capacity, product innovation and global patient demand are key drivers for the medical-device segment.
Where do these firms sit on the market?
They are classified within the healthcare sector, with several featuring in the FTSE100.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.